US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 24, 2018 (8 years ago)

Doxycycline Hyclate Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications:

What was recalled

Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-05.

Recalling firm
West-Ward Columbus Inc
NDC code
0143-2112-05
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1025-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Doxycycline recalls

See all
Class II · Moderate risk Ongoing

Doxycycline Hyclate Tablets

Reason Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

Acella Pharmaceuticals, LLC NDC 42192-501-05 D-0014-2026
Class II · Moderate risk Terminated

Doxycycline

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1182-2022
Class II · Moderate risk Terminated

Doxycycline Hyclate Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-0430-06 D-1054-2022
Class II · Moderate risk Terminated

Doxycycline Capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63304-616-50 D-1032-2022
Class II · Moderate risk Terminated

Doxycycline Capsules

Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Cardinal Healthcare NDC 68180-652-08 D-0178-2024